Condition
Mesothelioma; Pleura
Total Trials
4
Recruiting
2
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
P 1 (2)
P 2 (2)
Trial Status
Active Not Recruiting2
Recruiting2
Clinical Trials (4)
Showing 4 of 4 trials
NCT06477419Phase 2Recruiting
A Study of Sacituzumab Govitecan in People With Mesothelioma
NCT03907852Phase 1Active Not Recruiting
Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer
NCT07121374Phase 1Recruiting
NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study
NCT04300244Phase 2Active Not Recruiting
Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma
Showing all 4 trials